Bristol-Myers Squibb Company’s Fat Disorder Drug May Work, But Is Risky — FDA Staff

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An experimental Bristol-Myers drug to treat rare and potentially fatal disorders involving loss of body fat appears effective for some patients although with considerable safety risks, staff members of the U.S. Food and Drug Administration said on Monday.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC